Olaris, Inc to present non-invasive metabolic signature to detect over-immunosuppression in kidney transplant patients at International Transplant Science 2022 Meeting

Olaris, Inc is pleased to announce that the company’s study on the identification of a urine metabolic signature to detect over-immunosuppression in kidney transplant recipients has been selected for a presentation at the International Transplant Science (ITS) 2022 Annual Meeting, to be held May 15th-19th in Berlin, Germany. The presentation will describe the results of a multi-year collaboration between Olaris and Dr. Dirk Kuypers, Professor of Medicine and Chair of the Laboratory of Nephrology at the University of Leuven, to identify a biomarker for over-immunosuppression in kidney transplant recipients.

May 12, 2022

Olaris, Inc to present non-invasive metabolic signature to detect over-immunosuppression in kidney transplant patients at International Transplant Science 2022 Meeting